Ampion: Completed Phase III enrollment

Ampio completed enrollment of 480 patients in the double-blind, placebo-controlled, U.S. Phase III PIVOT trial evaluating single 4 mL intra-articular injections of Ampion. Ampio has an SPA from FDA fo...